New blood thinner better at preventing recurrent blood clots than aspirin

An international research team with prominent Canadian leadership has found that the blood thinner rivaroxaban is as safe as aspirin, and more effective at preventing recurrence of life-threatening blood clots in the legs and lungs, according to a study being published in the New England Journal of Medicine and presented at the American College of Cardiology’s 66th Annual Scientific Session.
Go to Source